Amputation · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon showed no clear difference in amputation compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review
Primary vessel patency · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon leads to higher primary vessel patency compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review
Target lesion revascularization · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon may leads to lower target lesion revascularization compared with uncoated balloon angioplasty at 12 months (low certainty).
1 finding from 1 review
Binary restenosis · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon probably leads to lower binary restenosis compared with uncoated balloon angioplasty at 12 months (moderate certainty).
1 finding from 1 review
Death · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon showed no clear difference in death compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review
Change in Rutherford category · people with peripheral arterial disease of the lower limbs
1 finding from 1 review
Change in ankle‐brachial index · people with peripheral arterial disease of the lower limbs
1 finding from 1 review
Amputation · patients with in‐stent restenosis of the femoropopliteal arteries
1 finding from 1 review
Target lesion revascularization · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes target lesion revascularization (TLR) compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Binary restenosis · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes binary restenosis compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Death · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes death compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Improvement ≥ 1 Rutherford category · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes improvement ≥ 1 Rutherford category compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review